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Introduction
The epidermal differentiation complex (EDC),
located on chromosomal band 1q21, consists of
multiple families of clustered genes that undergo
coordinate regulation during keratinocyte differen-
tiation (1). The EDC includes members of the
S100 and small proline rich region (SPRR) gene
clusters and additional cornified envelope genes
known to be structurally related to SPRR or S100
genes, including filaggrin, trichohyalin, and invol-
ucrin (2) (Fig.1). Recently, the EDC has also been
found to contain 18 additional genes encoding late
constituents of the epidermal cornified envelope
Abbreviations : 5AC: 5-azacytidine; EDC: epidermal differentiation com-
plex; NaB: sodium butyrate; NHK: normal human keratinocytes;
SPRR: small proline rich region.
Portions of this work were presented at the International Investigative
Dermatology 1998 meeting, Cologne, Germany, May, 1998.
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(3), the first of which was described by our group
(4). In all, at least 43 genes relevant to keratinocyte
differentiation are now known to be present in the
EDC. Clustering of the S100 and SPRR genes is
preserved in the mouse; however, the organization
of the S100 gene cluster is known to differ between
man and mouse (5). Two hypotheses have been ad-
Figure1. Map of the epidermal differentiation complex (EDC).
The 1q21–23 region of chromosome 1 is expanded once to illus-
trate the EDC, and again to illustrate the interval spanning
S100A1 and involucrin.
EDC gene regulation
vanced to explain the clustered organization of the
SPRR-like and S100 genes in the EDC: gene evolu-
tion via duplication and divergence, and coordi-
nate regulation. These hypotheses are not mutually
exclusive, and available evidence to date does not
allow either hypothesis to be excluded.
DNA methylation at CpG sites as well as
histone methylation and acetylation are epigenetic
mechanisms known to regulate chromatin struc-
ture (6,7). In this study, we have determined the
CpG methylation status of two EDC genes,
S100A2 and S100A6, in keratinocytes and fibro-
blasts. Interestingly, agents known to inhibit DNA
methylation (5-azacytidine, 5AC) and histone de-
acetylation (sodium butyrate, NaB) are also
known to inhibit growth and to promote differen-
tiation of keratinocytes (8–11). In this study, we
treated keratinocytes with both of these agents and
utilized two additional protocols for inducing
keratinocyte differentiation in vitro to investigate
the hypothesis that a global opening of chromatin
structure might be a rate-limiting factor leading to
coordinate up-regulation of clustered EDC genes.
While our results do not exclude a global opening
of EDC chromatin structure in keratinocytes, they
do suggest that at least some of the mechanisms
leading to tissue- and differentiation-specific ex-
pression of the EDC must be exerted locally on
specific EDC genes themselves.
Methods
Cells and tissues
Normal human fibroblasts and normal human keratinocytes
(NHK) were established from adult human skin as previously
described (12). Normal human fibroblasts were grown in
McCoy’s 5 A medium (Sigma, St. Louis, MO) containing 10%
fetal bovine serum (FBS). Normal human keratinocytes were
grown in MCDB153 medium modified (13) for high-density
KC growth (Medium 154, Cascade Biologics, Portland, OR),
or by coculture with irradiated mouse 3T3 fibroblasts in 3 : 1
DMEM : F12 medium supplemented with 5% FBS, insulin (5
mg/ml), EGF (10ng/ml), hydrocortisone (0.4mg/ml), adenine
(0.18mM), cholera toxin (0.1nM) and antibiotics, according to
the method of Rheinwald and Green (14). HaCaT cells, an im-
mortalized but differentiation-competent keratinocyte cell line
(15), were provided by Prof. Norbert Fusenig of the University
of Heidelberg and grown in Dulbecco’s modified Eagle’s me-
dium containing 10% FBS and antibiotics. C32 melanoma (16),
K562 erythroleukemia (17), Jurkat T cell (18), HL-60 myeloid
(19), and PA-1 teratocarcinoma (20) cell lines were obtained
from the American Type Culture Collection (Rockville, MD)
and propagated under the conditions recommended by the sup-
plier. B lymphoblastoid cells were obtained by Epstein-Barr vi-
rus transformation of lymphocytes from the peripheral blood
of a normal human volunteer, as previously described (21).
Normal and psoriatic human skin was obtained from adult hu-
man volunteers by keratome biopsy, after obtaining informed
consent. All procedures involving human subjects were ap-
proved by the Institutional Review Board of the University of
Michigan Medical School.
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Analysis of chromatin structure and gene
expression
DNA methylation assays were carried out as previously de-
scribed (22) by digesting genomic DNA from normal human
fibroblasts, NHK, and HaCaT cells with HpaII and MspI
endonucleases, which are methylation-sensitive and
methylation-resistant for cleavage, respectively. To perturb
chromatin structure, NHK were treated for 48h with 1–10mM
5AC, which inhibits CpG methylase (23), or with 1–10mM
NaB, which inhibits histone deacetylase (24). RNA isolation
from cultured cells and tissue samples and Northern blotting
were performed as previously described (25). cDNA clones en-
coding S100A2, S100A6, S100A7, S100A8, S100A9, loricrin,
SPRR-1, SPRR-2, SPRR-3, and involucrin were isolated from
cDNA libraries derived from human keratinocytes (Clontech,
Palo Alto, CA) or human skin (4,2-6). The specificity of the
various S100A probes was confirmed by hybridization to
Southern blots containing each of the plasmids (data not
shown). The plasmid p36B4, which encodes ribosomal phos-
phoprotein PO (27), served as a loading control. Purified cDNA
inserts were prepared, random-primed, and used as hybridiza-
tion probes for Northern blotting, as previously described (25).
Quantitation of blots was performed by densitometry of auto-
radiograms after normalization to 36B4.
To assess the effects of NaB on nuclear size, NHK cultures
were observed by phase-contrast microscopy and photographed
on slide film. The slides were projected and the long axis of
randomly selected cells were measured using a ruler. Size differ-
ences were assessed for significance using the Student’s paired t-
test and assuming equal variances and a two-tailed hypothesis.
Results
As a first step towards determining the role of
chromatin structure in the regulation of EDC
genes, we investigated the expression and
methylation status of the S100A2 and S100A6
genes in HaCaT cells, NHK, and normal human
fibroblasts (Fig.2). Lack of S100A2 expression in
fibroblasts was accompanied by a high degree of
CpG methylation, whereas high S100A2 expres-
sion in NHK was characterized by a near-complete
lack of methylation. S100A2 mRNA is expressed
at substantially lower levels in HaCaT cells than in
normal keratinocytes (26) (Fig.2). Consistent with
this, HaCaT cells also displayed greater CpG
methylation than did NHK. The pattern of
methylation also differed from that observed in
normal human fibroblasts. An inverse correlation
between DNA methylation and gene expression
was also observed for S100A6, with HaCaT cells
displaying the lowest expression and greatest
methylation, and fibroblasts displaying the greatest
expression and least methylation (Fig.2).
Next, NHK were treated with 5AC and NaB,
then the cells were observed for alterations in gene
expression and morphology. Both agents markedly
increased expression of SPRR1/2 and INV
mRNAs in NHK after 48h of treatment, which
would be consistent with an opening effect upon
chromatin structure. However, expression of
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Figure2. Expression of S100A2 and S100A6 correlates in-
versely with CpG methylation in keratinocytes and fibroblasts.
HC, HaCaT cells. Normal human keratinocytes (NHK). Nor-
mal human fibroblasts (FB). Top panels: Southern blots of gen-
omic DNA digested with Hpa II or Msp I as indicated at the
top of the figure, hybridized against S100A6 (left) or S100A2
(right). Bottom panels: Northern blots of total RNA extracted
from replicate dishes, hybridized against the probes indicated
to the right of each panel. Note that within a given cell type,
increasing mRNA expression (lower panels) is associated with
decreasing CpG methylation producing lower molecular weight
bands in the Hpa II digests (upper panels).
S100A2 mRNA was markedly reduced by both
agents (Fig.3a).
Sodium butyrate treatment of NHK caused a
significant increase in nuclear size. After 48h of
treatment with 1mM NaB, the long axis of nuclei
increased by 42%, from 2.6π0.3 (nΩ10) to 3.7π
0.2 (nΩ11) (arbitrary units) (PΩ0.0055). No com-
parable increase in nuclear size was detectable after
5AC treatment.
In order to determine whether the effects of
NaB might relate primarily to its effect on kera-
tinocyte differentiation, we repeated these experi-
ments on HaCaT cells. These cells are impaired
in their ability to cease proliferating after calcium-
mediated differentiation in vitro (15). Interestingly,
NaB promoted no down-regulation of S100A2 in
HaCaT cells, whereas it strongly down-regulated
S100A2 in NHK. NaB also failed to produce a
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Figure3. Differential responses of epidermal differentiation
complex genes after treatment of normal human keratinocytes
(NHK) with agents that promote ‘open’ chromatin structure.
Normal human keratinocytes at 20–30% confluence (a) were
treated for 48h with 5AC (1mM) or NaB (3mM). Northern
blots loaded with 10mg total RNA are shown. Hybridization
probes are indicated to the right of the blots. In the experiment
shown, a mixed probe consisting of equimolar amounts of 32P-
labelled SPRR-1 and SPRR-2 was used to detect SPRR-1 and
SPRR-2 simultaneously. Note that S100A2 is down-regulated,
whereas SPRR 1/2 and involucrin are up-regulated. Effects of
NaB and 5AC on S100A2 mRNA expression in HaCaT cells
(b). HaCaT cells at confluence were treated with NaB for 72h.
Northern blots loaded with 40mg total RNA are shown. Hy-
bridization probes are indicated to the right of the blots.
significant effect on nuclear size in HaCaT cells
(data not shown).
We next examined whether the expression of
clustered S100 genes within the EDC change in a
coordinated pattern when keratinocytes are stimu-
lated to differentiate in vitro. One of these methods
involves the growth of NHK on fibroblast feeder
layers in high-calcium, serum-containing medium
(14). The other method provokes a ‘psoriatic’ pat-
tern of differentiation by exposing NHK grown in
low-calcium, defined medium (M154) to serum
(28). These experiments revealed marked differ-
ences in the expression patterns of closely spaced
EDC gene regulation
Figure4. Differential S100 gene expression during keratinocyte
differentiation. Northern blots loaded with 20mg/lane total
RNA were hybridized against the 36B4 control gene (lower
panels) or against cDNA inserts derived from the genes de-
picted at the top of the figure (upper panels). Lane 1: Normal
human keratinocytes (NHK) grown in M154. Lane 2: postcon-
fluent Rheinwald-Green keratinocytes. Lane 3: postconfluent
Rheinwald-Green keratinocytes treated for 4h in medium con-
taining 10mM TPA. Lane 4: NHK grown in M154 π 0.1%
fetal calf serum (FCS) for 24h. Lane 5: NHK grown in M154
π 1% FCS for 24h. Lane 6: NHK grown in M154 π 10% FCS
for 24h.
EDC genes. S100A2 and S100A6 underwent little
or no up-regulation in response to either treat-
ment. In fact, these transcripts were moderately
down-regulated by 1% or 10% serum. As deter-
mined by densitometry, S100A2 mRNA was re-
duced by 40%, and S100A6 was down-regulated by
50%. In contrast, the S100A7, S100A8, and
S100A9 genes were markedly up-regulated by one
or both of these protocols (Fig.4).
In order to better compare the behaviour of
S100 and non-S100 genes residing within the EDC,
we analyzed Northern blots from NHK and
HaCaT keratinocytes, normal and psoriatic skin,
melanocytes, fibroblasts, and haematopoietic cell
lines derived from lymphoid, myeloid, and eryth-
roid lineages. A teratocarcinoma cell line was also
included as a representative of the germ line (Fig.
5). S100A2 and S100A6 were well expressed in un-
differentiated NHK, whereas the remaining S100
genes, loricrin, SPRR1, SPRR2, and involucrin
were not expressed (lane 2, Fig.5). Multiple EDC
genes were overexpressed in psoriatic lesions rela-
tive to normal skin. These included S100A2,
S100A6, S100A7, S100A8, and S100A9 as well as
SPRR2, SPRR1, and involucrin. Some of these
changes in expression have previously been re-
ported by the authors (29). However, S100A1
mRNA was not appreciably expressed in psoriatic
skin, and loricrin mRNA was actually down-regu-
lated in psoriatic lesions. Examining other cell
types, we found that S100A1 and S100A6 were
well expressed in melanoma cells, whereas the
S100A2 gene, which lies between S100A1 and
S100A6, was transcriptionally silent. S100A6 was
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the only EDC gene tested that was expressed in
fibroblasts, and S100A8 and A9 were expressed in
HL-60 myeloid leukaemia cells, as previously re-
ported (30). Otherwise, expression of EDC genes
appeared to be confined to keratinocytes.
Discussion
We have previously demonstrated coordinate regu-
lation of several EDC genes in skin lesions of pso-
riasis (29). By use of positional cloning, we have
also previously identified novel genes in the EDC
that are selectively expressed only in differentiating
keratinocytes (4). Our objective in this study was
to determine whether long-range alterations in
chromatin structure might be a rate-limiting factor
leading to coordinate regulation of EDC genes in
the keratinocyte lineage or during keratinocyte dif-
ferentiation.
An inverse correlation was identified between
gene expression and DNA methylation for the
S100A2 and S100A6 genes when assessed in
fibroblasts, NHK, and HaCaT cells (Fig.2). As
many studies have found a strong correlation be-
tween CpG methylation and ‘closed’ chromatin
(31), this result indicates that chromatin structural
alterations also participate in the control of genes
located in the EDC. However, the S100A6 gene
exists in a hypomethylated and transcriptionally
active chromatin structure in fibroblasts, whereas
the S100A2 gene, which resides approximately 30
kb away only, is highly methylated and transcrip-
tionally inactive in fibroblasts. These results sup-
port gene-specific rather than global effects of
chromatin structure on gene expression across the
S100 gene cluster in keratinocytes vs. fibroblasts.
The inverse correlation between CpG methylation
and gene expression is not perfect, as comparable
expression of S100A6 in NHK and fibroblasts oc-
curs in the presence of different amounts of
methylation. However, it is important to note that
methylation is only one of many factors control-
ling the expression of a given gene. It is possible
that NHK have a higher concentration of trans-
acting factors than do FB, allowing for compar-
able expression of the two genes despite different
levels of CpG methylation.
Sodium butyrate and 5AC treatment up-regu-
lated the expression of SPRR-1/2 and INV genes
in NHK (Fig.3a). Given that these agents promote
keratinocyte differentiation in vitro (8,9–11) and
promote ‘open’ chromatin structure (32,33), these
responses might be consistent with a need for
chromatin opening during keratinocyte differen-
tiation. However, both of these agents caused pro-
nounced down-regulation of S100A2 mRNA in
NHK (Fig.3a). Two lines of evidence suggest that
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Figure5. Differential epidermal differentiation complex (EDC) gene expression in various cell types, and in normal vs. psoriatic
skin. Each lane was loaded with 40mg total RNA. Replicate blots (three in all) were sequentially hybridized against cDNA inserts
derived from the genes indicated above the autoradiograms. Key to lanes: 1, HaCaT cells; 2, NHG grown in M154; 3, normal skin;
4, psoriatic skin; 5, C32 melanoma cells; 6, K562 erythroleukemia cells; 7, normal human fibroblasts; 8, Jurkat T cells; 9, HL-60
myeloid cells; 10, PA-1 teratocarcinoma cells; and 11, Epstein-Barr virus-transformed B lymphoblasts. Each blot was also hybridized
with 36B4, revealing equal loading of all lanes (data not shown).
the inhibitory effect of these agents on S100A2
mRNA is a consequence of activation of the kera-
tinocyte differentiation program. First, NaB did
not reduce S100A2 mRNA levels in HaCaT cells,
which are relatively resistant to the antiproliferat-
ive effects of calcium-induced keratinocyte differ-
entiation (15) (Fig.3b). This finding suggests that
HaCaT cells are also impaired in their capacity to
undergo NaB-induced differentiation, and that the
changes in S100A2 expression induced by NaB
may reflect the known effects of this agent on kera-
tinocyte differentiation, rather than a global open-
ing of EDC chromatin structure. We and others
have shown that S100A2 protein is strongly ex-
pressed in the basal cell layer in vivo, and markedly
diminishes as keratinocytes exit the basal layer
[(34); Tong Zhang and James Elder, unpublished
results]. Second, S100A2 (and S100A6) were mod-
erately (40–50%) down-regulated in NHK treated
with 1 or 10% serum (Fig.4), which is known to
markedly suppress proliferation and stimulate pso-
riasis-like differentiation of keratinocytes (28). It is
true that S100A2 continued to be expressed when
keratinocytes were cultured on fibroblast feeder
layers, despite the presence of serum and high cal-
cium concentrations (Fig.4). However, in this cul-
ture system, keratinocyte proliferation is main-
tained in the lowermost cell layer, while differen-
tiation occurs in the upper layers (14).
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We observed a 42% increase in nuclear diameter
after two days of NaB treatment. This increase was
statistically significant (PΩ0.0055). Keratinocytes
stimulated to differentiate by calcipotriol are also
known to undergo an increase in nuclear size (35).
Moreover, keratinocyte have been observed to in-
crease from 107 to 193mM2 as a consequence of
suspension-induced differentiation (36). We ob-
served no increase in nuclear size after treatment
of differentiation-resistant HaCaT cells with NaB
(data not shown). Thus, the observed effect of
NaB on nuclear size could reflect cell cycle arrest
or some other aspect of keratinocyte differen-
tiation, rather than a direct effect of NaB on
chromatin structure by increasing histone acety-
lation. This increase in nuclear size could be a re-
flection of increased transcriptional activity, as
keratinocyte differentiation in vitro is associated
with a large increase in RNA content (37).
The interpretation that 5AC also acts on EDC
genes primarily by promoting keratinocyte differ-
entiation would also explain an apparent paradox:
5AC treatment increased expression of S100A2
mRNA in breast carcinoma cell lines (38), but de-
creased its expression in NHK (Fig.3a).
Methylation of CpG sites in the S100A2 gene is
increased in breast carcinoma cell lines and tissues,
relative to benign mammary epithelial cells (39).
Up-regulation of S100A2 by 5AC reflects reversal
EDC gene regulation
of this methylation in breast carcinoma cells (38).
In contrast, NHK express high levels of S100A2
mRNA, and S100A2 is hypomethylated in NHK,
relative to fibroblasts or to immortalized HaCaT
keratinocytes (Fig.2). Thus, it would be difficult
for 5AC to further increase S100A2 mRNA levels
by reversing an already-low level of methylation.
Rather, we would suggest that the reduced expres-
sion of S100A2 after 5AC treatment of NHK
probably reflects inhibition of keratinocyte pro-
liferation and/or induction of keratinocyte differ-
entiation by this agent.
We compared the expression of S100 vs. non-
S100 genes of the EDC in normal vs. psoriatic skin
sampled from human volunteers and in several dif-
ferent cell types (Fig.5). S100 and non-S100 EDC
genes did appear to be more consistently expressed
in keratinocytes than in any other cell type tested.
However, there were a number of exceptions to this
generalization. S100A1 was strongly expressed in
melanoma cells but only weakly expressed in skin
and keratinocytes. S100A6 was strongly expressed
in fibroblasts and melanocytes, and S100A8 and
A9 were expressed in myeloid cells (Fig.5).
S100A2, which is adjacent to S100A1, was not ex-
pressed in melanoma cells as previously reported
(40). We also confirmed our previous observation
of widespread overexpression of EDC gene expres-
sion in psoriatic lesions compared with normal
skin (29). However, two exceptions to global up-
regulation of EDC gene expression in psoriatic
lesions were identified (S100A1 and loricrin). As
previously reported (41), SPRR-3 was not appre-
ciably expressed in keratinocytes or skin. Thus,
again our results do not appear to support a ‘glo-
bal’ mode of gene regulation across the EDC.
Taken together, our results do not support a
monolithic global mode of tissue-specific gene
regulation extending across the EDC. They are
also inconsistent with (but do not necessarily rule
out) a global opening of EDC chromatin structure
across the EDC during keratinocyte terminal dif-
ferentiation, as S100A2 and S100A6 were down-
regulated in NHK by 5AC, NaB, and induction of
differentiation by serum. Overall, our findings are
consistent with the emerging understanding of the
gene-specific effects of coactivators such as p300
and PCAF: not only are such factors required for
recruitment of the transcriptional machinery, but
they are also necessary for generation of an ‘open’
chromatin template by virtue of their intrinsic
histone acetyltransferase activities (42). Neverthe-
less, our results, and those of many other groups,
do demonstrate a predilection for multiple EDC
genes to be expressed in keratinocytes. Recently,
Ragoussis and colleagues have reported that the
EDC is frequently positioned external to the
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chromosome 1 territory in keratinocyte interphase
nuclei, whereas it tends to remain within the
chromosome 1 territory in cells such as lympho-
blasts, in which EDC genes are not expressed (40).
These findings provide evidence for higher-order
organization of transcriptional activity within the
keratinocyte nucleus, and suggest that the spatial
proximity of EDC genes may provide a ‘platform’
for some level of coordinate regulation of EDC
gene expression. Our results would suggest that
even if such a global mechanism for opening EDC
chromatin is operative in keratinocytes, gene-speci-
fic mechanisms must also be operative as well. Ad-
ditional studies taking advantage of recently de-
veloped methods for the definition of chromatin
structure via patterns of histone modification (7)
are clearly warranted to address the regulation of
EDC gene expression in greater detail.
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